Mengo, Myrjhon T.
HRN: 29-25-17 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
AMPICILLIN 250MG (VIAL)
07/20/2026
07/27/2026
IV
160mg
Q 6
UTI
Checking Final Appropriateness
07/20/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2026
07/27/2026
IV
48mg
Q 24
UTI
Checking Final Appropriateness